Just as cities must carefully manage the flow of cars in and out of downtown, cells regulate the movement of molecules into ...
Tania Gendron, PhD, speaks to the present challenges for translating biomarker discoveries to clinical practice and offers ...
Raziel Green, 52, an active runner and mother of two, was diagnosed with a rare form of ALS in 2017. Since starting a clinical trial nearly eight years ago, her symptoms have not gotten any worse.
Neurologists have grappled with a cluster of amyotrophic lateral sclerosis cases in France, where a fondness for a toxic wild ...
Once daily treatment with Denali's oral candidate DNL343 failed to reduce NfL levels in adults with ALS in the HEALEY trial.
QRL-101-03 (NCT06532396) is a randomized, double-blind, placebo-controlled, multiple-ascending dose clinical trial evaluating the safety, tolerability, and PK of QRL-101 in up to 60 healthy ...
A new study compares three types of blood biomarkers: neurofilament light chain proteins, glial acidic proteins and ...
Pathmaker's MyoRegulator is designed to ease hyperexcitability and delivers an electrical current to the spinal cord and ...
As global populations age, neurological disorders such as Alzheimer's, Parkinson's, and epilepsy become more prevalent.
ALS Walk in Elbow is on the Horizon and registration is finally open. On Sunday, June 8, the walk starts from the Elbow ...
Amyotrophic lateral sclerosis (ALS) – also known as Lou Gehrig’s disease – is a progressive neurodegenerative disease affecting nerve cells in the brain and spinal cord, robbing people of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback